UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052168
Receipt number R000059540
Scientific Title Study on post-drinking performance after ingestion of test foods
Date of disclosure of the study information 2023/09/11
Last modified on 2024/03/12 09:18:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on post-drinking performance after ingestion of test foods

Acronym

Study on post-drinking performance after ingestion of test foods

Scientific Title

Study on post-drinking performance after ingestion of test foods

Scientific Title:Acronym

Study on post-drinking performance after ingestion of test foods

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To exploratorily evaluate the attenuating effect of a single dose of a test food on post-drinking performance decline in adults aged 20 to 64 years

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Uchida Kraepelin test

Key secondary outcomes

VAS questionnaire on physical condition
OSA sleep inventory MA version
Brain waves
ADH1C and ADH1B polymorphisms


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Total of 600 mg of the test food before and after drinking alcohol (180 mL of clear alcohol (15% alcohol)).
Washout for 1week or more.
Total of 600 mg of the placebo before and after drinking alcohol (180 mL of clear alcohol (15% alcohol)).

Interventions/Control_2

Total of 600 mg of the placebo before and after drinking alcohol (180 mL of clear alcohol (15% alcohol)).
Washout for 1week or more.
Total of 600 mg of the test food before and after drinking alcohol (180 mL of clear alcohol (15% alcohol)).

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

64 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2.Japanese who are 20 years old or more and under 64 years old
3.Persons who are aware of a decline in performance the day after drinking

Key exclusion criteria

1.Persons who have chronic illness, receiving medication, have a serious disease history
2.Persons who are allergic to the test food or alcohol
3.Persons who normally consume large amounts of the test food
4.Persons who regularly use medicines or foods with health claims (foods for specified health use, foods with functional claims and foods with nutritional claims) etc., that may affect alcohol metabolism and sleep quality
5.Persons who have participated in other tests within the past one month before the start of test, or those who intend to participate in another exam after consenting to the exam
6.Persons who were judged as inappropriate for study participant by the principal investigator
7.Persons who are breast-feeding, pregnant and planning or wishing to become pregnant during the study period

Target sample size

5


Research contact person

Name of lead principal investigator

1st name Kosei
Middle name
Last name Nishikawa

Organization

Healthcare Systems Co., Ltd.

Division name

Clinical Research Department

Zip code

105-0004

Address

Park Place 5F, 5-27-1 Shinbashi, Minato-ku, Tokyo, JAPAN

TEL

03-6809-2722

Email

nishikawa@hc-sys.jp


Public contact

Name of contact person

1st name Kosei
Middle name
Last name Nishikawa

Organization

Healthcare Systems Co., Ltd.

Division name

Clinical Research Department

Zip code

105-0004

Address

Park Place 5F, 5-27-1 Shinbashi, Minato-ku, Tokyo, JAPAN

TEL

03-6809-2722

Homepage URL


Email

nishikawa@hc-sys.jp


Sponsor or person

Institute

Healthcare Systems Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Musashi Seimitsu Industry Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Healthcare Systems Co., Ltd.

Address

1-14-18 Shirakane, Showa-ku, Nagoya city, Aichi, JAPAN

Tel

052-734-8885

Email

soumu@hc-sys.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 09 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

5

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 09 Month 11 Day

Date of IRB

2023 Year 09 Month 11 Day

Anticipated trial start date

2023 Year 09 Month 11 Day

Last follow-up date

2023 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 09 Month 11 Day

Last modified on

2024 Year 03 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059540